Company Profile

NATH BIO-GENES (INDIA) LTD.

NSE : NATHBIOGENBSE : 537291ISIN CODE : INE448G01010Industry : AgricultureHouse : Private
BSE266.00-3.3 (-1.23 % )
PREV CLOSE (Rs.) 269.30
OPEN PRICE (Rs.) 268.10
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 3654
TODAY'S LOW / HIGH (Rs.)265.00 271.75
52 WK LOW / HIGH (Rs.)126.25 415.5
NSE265.60 -3.15 (-1.17 % )
PREV CLOSE(Rs.) 268.75
OPEN PRICE (Rs.) 268.40
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 18689
TODAY'S LOW / HIGH(Rs.) 264.65 271.40
52 WK LOW / HIGH (Rs.)127.3 416

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 9.75992
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 18.04
ROCE (%) 9.24
Incorporation Year : 2000

Management Info :

- Chairman Satish Kagliwal - Managing Director

Registered Office :

Address : Nath House, Nath Road,P B No 318,,
Aurangabad,
Maharashtra-431005

Phone : 0240-2376314

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE, NSE, Ahmedabad
NEWS More
12Feb02-12-2021$Nath Bio-Genes (India) informs about presentation Nath Bio-Genes (India) infor

Nath Bio-Genes (India) has informed that it has attached the presentation on unaudited financial results for the period ended 31st December 2020.

The above information is a part of company’s filings submitted to BSE.


Nath Bio-Genes (India) has informed that it has attached the pr..
10Feb02-10-2021$Appointment of Director Appointment of Director
inter alia, approved 1.Appointment of Mr. Madhukar Deshpande (DIN-07630081) as Independent Director (Additional) with immediate effect.
inter alia, approved 1.Appointment of Mr. Madhukar Deshpande (D..
03Feb02-03-2021$ Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter End 31St December 2020. Board Meeting Intimation fo
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2021 ,inter alia, to consider and approve unaudited financial results for the quarter end 31st December 2020.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of..
29Jan01-29-2021$ Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015. Announcement Under Regulati
Intimation of Retirement of Mr. Madhav Dhande (Marketing Lead)
Intimation of Retirement of Mr. Madhav Dhande (Marketing Lead)
29Oct10-29-2020$Nath Bio-Genes (India) to hold board meeting Nath Bio-Genes (India) to ho

Nath Bio-Genes (India) has informed that the meeting of the Board of Directors of the Company is scheduled on 07/11/2020, to consider and approve unaudited financial results for the quarter and half year ended 30th September 2020.

The above information is a part of company’s filings submitted to BSE.

Nath Bio-Genes (India) has informed that the meeting of the Boa..
Financials More
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit42.48504.84
Gross Profit 45.4 485.1
Operating Profit 73.11565.09
Net Sales 360.312817.15
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Dhunseri Tea (BSE)
 274.90 (1.97%)
M.Cap ( in Cr)
192.57
Shree Ganesh BioTech (BSE)
 125.00 (3.31%)
M.Cap ( in Cr)
249.14
Joonktollee Tea&Inds (BSE)
 114.45 (2.19%)
M.Cap ( in Cr)
47.41
Harrisons Malayalam (BSE)
 131.20 (0.88%)
M.Cap ( in Cr)
242.13
Saptarishi Agro Inds (BSE)
 10.84 (4.94%)
M.Cap ( in Cr)
36.84
Shareholding Pattern More
MUTUAL FUNDS/UTI 8.55 %
NON-INSTITUTION 47.17 %
PROMOTERS 41.79 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes